Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joris R de Groot

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 16, 2025
Left atrial appendage occlusion vs standard of care in high stroke risk atrial fibrillation patients ineligible for anticoagulation: COMPARE-LAAOErrol W Aarnink, Marina F M Huijboom, Frank van der Kley, et al.
BMC Anesthesiology|May 25, 2011
Effect of remote ischemic conditioning on atrial fibrillation and outcome after coronary artery bypass grafting (RICO-trial)Daniel Brevoord, Markus W Hollmann, Stefan G De Hert, et al.
Revista Espanola De Cardiologia (English Ed.)|September 26, 2022
A failed catheter ablation of atrial fibrillation is associated with more advanced remodeling and reduced efficacy of further thoracoscopic ablationRobin Wesselink, Mindy Vroomen, Ingrid Overeinder, et al.
Nature Communications|October 21, 2018
Neurokinin-3 receptor activation selectively prolongs atrial refractoriness by inhibition of a background K<sup>+</sup> channelMarieke W Veldkamp, Guillaume S C Geuzebroek, Antonius Baartscheer, et al.
Cardiovascular Diabetology|December 26, 2025
Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuationEva R Meulendijks, Benedetta Fabrizi, Steffen Bruns, et al.
Heart Rhythm|July 31, 2021
Extracellular matrix remodeling precedes atrial fibrillation: Results of the PREDICT-AF trialNicoline W E van den Berg, Jolien Neefs, Makiri Kawasaki, et al.
Journal of Translational Medicine|June 6, 2023
Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillationEva R Meulendijks, Rushd F M Al-Shama, Makiri Kawasaki, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 10, 2020
Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE VRuben R De With, Ömer Erküner, Michiel Rienstra, et al.
Molecular Therapy. Methods & Clinical Development|August 8, 2025
AAV6 vectors provide superior gene transfer compared to AAV9 vectors following intramyocardial administrationJianan Wang, Timo Jonker, Aina Cervera-Barea, et al.
American Heart Journal|May 22, 2012
Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapyLouise R A Olde Nordkamp, Reinoud E Knops, Gust H Bardy, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 16, 2025
Left atrial appendage occlusion vs standard of care in high stroke risk atrial fibrillation patients ineligible for anticoagulation: COMPARE-LAAOErrol W Aarnink, Marina F M Huijboom, Frank van der Kley, et al.
BMC Anesthesiology|May 25, 2011
Effect of remote ischemic conditioning on atrial fibrillation and outcome after coronary artery bypass grafting (RICO-trial)Daniel Brevoord, Markus W Hollmann, Stefan G De Hert, et al.
Revista Espanola De Cardiologia (English Ed.)|September 26, 2022
A failed catheter ablation of atrial fibrillation is associated with more advanced remodeling and reduced efficacy of further thoracoscopic ablationRobin Wesselink, Mindy Vroomen, Ingrid Overeinder, et al.
Nature Communications|October 21, 2018
Neurokinin-3 receptor activation selectively prolongs atrial refractoriness by inhibition of a background K<sup>+</sup> channelMarieke W Veldkamp, Guillaume S C Geuzebroek, Antonius Baartscheer, et al.
Cardiovascular Diabetology|December 26, 2025
Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuationEva R Meulendijks, Benedetta Fabrizi, Steffen Bruns, et al.
Heart Rhythm|July 31, 2021
Extracellular matrix remodeling precedes atrial fibrillation: Results of the PREDICT-AF trialNicoline W E van den Berg, Jolien Neefs, Makiri Kawasaki, et al.
Journal of Translational Medicine|June 6, 2023
Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillationEva R Meulendijks, Rushd F M Al-Shama, Makiri Kawasaki, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 10, 2020
Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE VRuben R De With, Ömer Erküner, Michiel Rienstra, et al.
Molecular Therapy. Methods & Clinical Development|August 8, 2025
AAV6 vectors provide superior gene transfer compared to AAV9 vectors following intramyocardial administrationJianan Wang, Timo Jonker, Aina Cervera-Barea, et al.
American Heart Journal|May 22, 2012
Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapyLouise R A Olde Nordkamp, Reinoud E Knops, Gust H Bardy, et al.
Pageof 19